Overview
Marie-christine Jacob practices in Grenoble, France. Ms. Jacob is highly rated in 3 conditions, according to our data. Her top areas of expertise are Aleukemic Leukemia Cutis (ALC), Myelodysplastic Syndrome (MDS), Acute Monoblastic Leukemia (AmoL), Leukemia, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow AspirationMs. Jacob isDistinguished. Learn about Bone Marrow Aspiration.
- Advanced
- Aleukemic Leukemia Cutis (ALC)Ms. Jacob isAdvanced. Learn about Aleukemic Leukemia Cutis (ALC).
- Myelodysplastic Syndrome (MDS)Ms. Jacob isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Monoblastic Leukemia (AmoL)Ms. Jacob isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- B-Cell LymphomaMs. Jacob isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Jacob isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Jacob isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelomonocytic Leukemia (CMML)
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Jacob isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).